Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BrosMed Closes C Round for Vascular Devices Led by Hillhouse

publication date: Jul 27, 2020

BrosMed Medical, a Dongguan maker of interventional medical devices, raised "hundred of millions of RMB" in a C Round led by Hillhouse Capital. BrosMed makes high quality devices for cardiovascular, endovascular and neurovascular indications that it markets in China and western countries, including the US and EU. Its goal is to make medical devices that are simpler, better and more cost efficient. The company will use the proceeds to promote product development, expand its market and increase production. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital